Viglip Tablets 50Mg (1 Strip = 14 Tablets)

The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased...

PKR 1100.12

PKR 1045.11

You save: PKR 55.01

Quantity:

SKU: VIGLIP_TABLETS_50_MG_28S_NV

Category: Medicines

The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).

Purpose

Diabetes

Ingredients

Vildagliptin

Warnings

Vildagliptin is advised to not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
In diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.
Use of vildagliptin has been associated with a risk of developing acute pancreatitis. If pancreatitis is suspected, vildagliptin is advised to be discontinued and if acute pancreatitis is confirmed, vildagliptin is advised to not be restarted. Caution is advised to be exercised in patients with a history of acute pancreatitis.

Side Effects

Monotherapy Common: Dizziness. Uncommon: Hypoglycemia, headache, edema peripheral, constipation & arthralgia. Very Rare: Upper respiratory tract infection & nasopharyngitis. Combination with Metformin Common: Hypoglycemia, tremor, headache, dizziness & nausea. Uncommon: Fatigue. Combination with Sulfonylurea Common: Hypoglycemia, tremor, headache, dizziness & asthenia. Uncommon: Constipation. Very Rare: Nasopharyngitis. Combination with Thiazolidinedione Common: Weight increase & edema peripheral. Uncommon: Hypoglycemia, headache & asthenia. Combination with Metformin and Sulfonylurea Common: Hypoglycemia, dizziness, tremor, hyperhidrosis & asthenia. Combination with Insulin Common: Decreased blood glucose, headache, chills, nausea, gastroesophageal reflux disease. Uncommon: Diarrhea & flatulence.